Published in
Wiley, Clinical and Experimental Dermatology, 11(48), p. 1272-1274, 2023
DOI: 10.1093/ced/llad229
Links
Tools
Bimekizumab in hidradenitis suppurativa: a valid and effective emerging treatment
Journal article published in 2023 by
Elisa Molinelli,
Daisy Gambini,
Andrea Maurizi,
Edoardo De Simoni 
,
Claudia Sapigni,
Sara Belleggia,
Giulio Rizzetto,
Annamaria Offidani,
Oriana Simonetti
,
Claudia Sapigni,
Sara Belleggia,
Giulio Rizzetto,
Annamaria Offidani,
Oriana Simonetti
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 
Abstract
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease in which many inflammatory mediators such as interleukin-17 are involved in the pathophysiology. We describe a rapid improvement in the skin lesions of HS in patients with psoriasis treated with bimekizumab.